Given the high prevalence of the atherogenic forms of apolipoprotein B (apoB) dyslipoproteinemias and the effectiveness of appropriate therapy, we feel that access for all physicians to simple, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results